Sr. Field Reimbursement Manager, Global Rare Diseases
Chiesi Group
Summary
The Field Reimbursement Manager will offer field-based reimbursement education and patient access expertise to leading HAE centers and the healthcare provider (HCP) community. This role is crucial to ensure that patients successfully initiate and maintain therapy. Acting as the primary contact for all reimbursement and access-related inquiries, the Field Reimbursement Manager will collaborate with the Regional Disease Account Managers (RDAMs), HCPs, specialty pharmacies, payers, patients, and our HUB vendor partner.
Job description
Responsibilities
- Provide compliant reimbursement and access education to designated accounts within the assigned territory (Minneapolis, MN & Chicago, IL)
- Collaborate cross-functionally with key partners and vendors to ensure a seamless experience for patients and healthcare professionals (HCPs)
- Work cross-functionally with internal teams to support seamless, uninterrupted access for patients and providers across the product lifecycle
- Serve as a subject matter expert to prevent and address access and reimbursement issues, providing proactive education and problem-solving strategies
- Provide education on affordability assistance options including copay assistance
- Provide non-medical, educational support including what to expect when initiating therapy
- Work seamlessly and in coordination with patient support services, specialty pharmacies, HUB vendor partner and other field teams to support patient access
- Demonstrate the ability to partner cross-functionally in a matrix environment to enhance the experience of patients and providers
Requirements
- Bachelor’s Degree
- 8+ years of experience in the biopharmaceutical industry including Pharmaceutical/Rare Disease Sales, Access & Reimbursement, Market Access or other relevant expertise
- 3+ years in Access and Reimbursement
- Rare disease reimbursement experience in the US
- Experience working with 3rd party HUB
- Innovative mindset with the ability to meet the needs of internal and external customers
- Understand HIPAA rules and regulations related to patient privacy
- Must display a patient-centric mentality with a high degree of emotional intelligence and empathy
Preferred Qualifications
- Previous experience working in a commercial-stage biotech company
- Experience working directly with patients strongly preferred
- Rare disease experience supporting access for a commercially available (in-line) product in the US
Requirements
- Bachelor’s Degree
- 8+ years of experience in the biopharmaceutical industry including Pharmaceutical/Rare Disease Sales, Access & Reimbursement, Market Access or other relevant expertise
- 3+ years in Access and Reimbursement
- Rare disease reimbursement experience in the US
- Experience working with 3rd party HUB
- Innovative mindset with the ability to meet the needs of internal and external customers
- Understand HIPAA rules and regulations related to patient privacy
- Must display a patient-centric mentality with a high degree of emotional intelligence and empathy
Benefits
- Comprehensive healthcare programs
- Work-life balance initiatives
- Relocation support
- Performance bonuses
- Flexible working arrangements
- Remote work options
- Tax assistance services
Company overview
Chiesi Group is a research-oriented international biopharmaceutical company headquartered in Parma, Italy, with over 85 years of experience in the pharmaceutical industry. Founded in 1935 as a family-owned business, Chiesi has grown into a global pharmaceutical group with 31 affiliates worldwide and more than 7,500 employees. The company specializes in developing and marketing innovative therapeutic solutions across three main business areas: respiratory health (AIR), rare diseases (RARE), and specialty care (CARE). Chiesi is particularly recognized for its leadership in respiratory treatments, including inhalers for asthma and COPD, as well as its growing portfolio in rare disease therapies following the acquisition of Amryt Pharma. As a certified B Corporation since 2019 and a Benefit Corporation in Italy, the US, France, and Colombia, Chiesi is committed to sustainable business practices and has set ambitious goals to achieve net-zero greenhouse gas emissions by 2035. The company invests significantly in R&D, allocating over 24% of its revenues to research and development, making it one of the top Italian pharmaceutical companies for R&D investment. With a strong global presence and a focus on patient-centered innovation, Chiesi continues to expand its therapeutic offerings while maintaining its commitment to social and environmental responsibility.